Cited by 483Antifungal resistance and susceptibilityBacterial biofilms and quorum sensingFungal and yeast genetics research

Our Current Understanding of Fungal Biofilms

Ramage, Gordon, Mowat, Eilidh, Jones, Brian, Williams, Craig, Lopez-Ribot, Jose·2009·Critical Reviews in Microbiology

Abstract

Gordon Ramage*a, Eilidh Mowata, Brian Jonesb, Craig Williamsc & Jose Lopez-Ribotda Section of Infection and Immunity, Glasgow Dental School and Hospital, Faculty of Medicine, University of Glasgow, UKb Microbiology Department, Glasgow Royal Infirmary, The University of Texas at San Antonio, San Antonio, Texas, USAc Microbiology Department, Royal Hospital for Sick Children, Yorkhill Division, The University of Texas at San Antonio, San Antonio, Texas, USAd Department of Biology and South Texas Center for Emerging Infectious Diseases, The University of Texas at San Antonio, San Antonio, Texas, USAAddress for Correspondence: Gordon Ramage, Section of Infection and Immunity, Glasgow Dental School, Faculty of Medicine, University of Glasgow, 378 Sauchiehall Street, Glasgow, G2 3JZ, UK. Phone: +44(0)141 211 9752. Fax: +44(0) 141. e-mail: 0141 353 1593. e-mail: g.ramage@dental.gla.ac.ukFungal biofilms are an escalating clinical problem associated with significant rates of mortality. Candida albicans is the most notorious of all fungal biofilm formers. However, non-Candida species, yeasts such as Cryptococcus neoformans, and filamentous moulds such as Aspergillus fumigatus, have been shown to be implicated in biofilm-associated infections. Fungal biofilms have distinct developmental phases, including adhesion, colonisation, maturation and dispersal, which are governed by complex molecular events. Recalcitrance to antifungal therapy remains the greatest threat to patients with fungal biofilms. This review discusses our current understanding of the basic biology and clinical implications associated with fungal biofilms.

Integrity signals

Registry

Crossref · 10.3109/10408410903241436

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Biofilm growth leads to inherent resistance to antimicrobial agents, connected with increased expression of efflux pumps, extracellular matrix formation, and persister cells.

    “Biofilm growth leads to inherent resistance to antimicrobial agents, a phenomenon connected with the increased expression of efflux pumps, the formation of the extracellular matrix, and the presence of persister cells [84,85].”
  • C. albicans produces highly structured biofilms composed of multiple cell types encased in an extracellular matrix.

    “C. albicans produces highly structured biofilms composed of multiple cell types (i.e., round, budding yeast-form cells; oval pseudohyphal cells; and elongated, cylindrical hyphal cells) encased in an extracellular matrix (23, 61, 158, 161).”

    From <i>Candida albicans</i> Biofilms and Human Disease (2015) · cites this paper as [158]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J.
Affiliations
  • University of Glasgow (GB)
  • The University of Texas at San Antonio (US)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Ramage, Gordon
Venue
Critical Reviews in Microbiology
Published
2009-10-28
Volume
35
Issue
4
Pages
340-355
ISSN
  • 1040-841X (ISSN-L)
  • 1549-7828
OpenAlex
W2073130572
Cited by
483
References
201
Citations by year
2026: 13 · 2025: 16 · 2024: 18 · 2023: 27 · 2022: 21 · 2021: 33 · 2020: 30 · 2019: 28 · 2018: 25 · 2017: 28 · 2016: 34 · 2015: 35 · 2014: 45 · 2013: 39 · 2012: 42
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Locations
  • Critical Reviews in Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
Keywords
fungal biofilms, Candida albicans, Cryptococcus neoformans, Aspergillus fumigatus, biofilm growth, biofilm dispersal, antifungal resistance, biofilm-associated infections
MeSH terms
Animals, Fungal Proteins, Fungi, Humans, Mycoses, Biofilms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review